Journal of Pulmonology and Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Journal of Pulmonology and Clinical Research (2022) Volume 5, Issue 3

Current understanding and mechanisms of cardiogenic pulmonary edema in COVID-19 patients.

Ballaz Mamoru*

Faculty of Medicine, Karabuk University, Karabuk 78100, Turkey

*Corresponding Author:
Ballaz Mamoru
Faculty of Medicine
Karabuk University
Karabuk 78100, Turkey

Received: 29-Apr-2022, Manuscript No. AAJPCR-22-63018; Editor assigned: 03-May-2022, Pre QC No. AAJPCR-22-63018(PQ); Reviewed: 17-May-2022, QC No. AAJPCR-22-63018; Revised: 20-May-2022, Manuscript No. AAJPCR-22-63018(R); Published: 27-May-2022, DOI: 10.35841/aajpcr-5.3.115

Citation: Mamoru B. Current understanding and mechanisms of cardiogenic pulmonary edema in COVID-19 patients. J Pulmonol Clin Res. 2022;5(3):115

Visit for more related articles at Journal of Pulmonology and Clinical Research


Aspiratory edema can be characterized as an unusual collection of extravascular liquid in the lung parenchyma. This interaction prompts reduced gas trade at the alveolar level, advancing to possibly causing respiratory disappointment. Its etiology is either due to a cardiogenic cycle with the powerlessness to eliminate adequate blood away from the aspiratory flow or noncardiogenic hastened by injury to the lung parenchyma. It is a significant pathologic component in numerous sickness processes, and subsequently learning the basic infection process is urgent to direct its administration. Clinical elements incorporate moderate demolishing dyspnea, rales on lung auscultation, and deteriorating hypoxia. Pneumonic edema alludes to the gathering of over the top liquid in the alveolar dividers and alveolar spaces of the lungs. It very well may be a dangerous condition in certain patients with high mortality and requires prompt appraisal and the board. This action audits the pathophysiology, clinical show, assessment, and the board of cardiogenic aspiratory edema and features the job of interprofessional colleagues in working together to give all around facilitated care and upgrade patient results.


COVID-19 patients, Pulmonary edema.


Edema alludes to inordinate liquid collection in the interstitial spaces, underneath the skin or inside the body cavities brought about by any of the accompanying and delivering huge signs and side effects.

• An awkwardness among the "Starling powers."

• Harm/blockage of the depleting lymphatic framework.

• The impacted body part generally expands assuming edema is available underneath the skin or delivers critical signs and side effects connected with the body pit included.

There are a few distinct sorts of edema, and few significant are the fringe edema, pneumonic edema, cerebral edema, macular edema, and lymphedema. The abnormal structures are the idiopathic edema and innate angioneurotic edema. Aspiratory edema alludes to the amassing of over the top liquid in the alveolar dividers and alveolar spaces of the lungs. It tends to be a dangerous condition in certain patients. Pneumonic edema can be: Cardiogenic (upset starling powers including the pneumonic vasculature and interstitium).Non-Cardiogenic (direct injury/harm to lung parenchyma/vasculature).

Components of cardiogenic pulmonary edema in COVID-19 patients

Coronavirus, an irresistible infection brought about by a serious intense respiratory disorder Covid 2 (SARS-CoV-2), has a worldwide reach. By March 31st of 2021, an aggregate of 128.54 million instances of extreme Coronavirus Disease (COVID-19) have been analyzed around the world, and a sum of 2.81 million individuals have kicked the bucket from the infection. Presently, no particular medication has been created to against COVID-19, albeit a few existing medications have been reused and supported for treating hospitalized patients. As of late, a few organizations emerged with immunizations against COVID-19 which have been supported for use. Some others will probably be endorsed soon. Be that as it may, it is as yet muddled how the inoculation will continue and how quick immunizations should be possible. Meanwhile, we desperately need powerful decrease in casualty of COVID-19 [1].

Pneumonic edema is the disequilibrium among arrangement and reflux of lung tissue liquid prompting the retention of monstrous tissue liquid by lung lymph and vein disappointment. The liquid sweats into and collects in the interstitium of lungs lastly alveolars from lung narrow, prompting serious turmoil of pneumonic ventilation and gas trade. In COVID-19 patients, pneumonic edema is analyzed by lung ultrasound and a mechanized tomography (CT) examine. The condition introduces itself as a gradually advancing pneumonia with tricky beginning stage interstitial aspiratory edema that goes through intense compounding in the late stages and alveolar edema. At present, these side effects are the essential results of aspiratory infection contamination. It is realized that SARS-CoV-2 attacks human cells by restricting angiotensin-changing over catalyst 2 (ACE-2) receptor and other layer ectopeptidases. At the point when there, the actual infection and infection interceded protein associations lead to the lung incendiary tempest liable for the noticed expanding vascular penetrability in lung and aspiratory edema. Almost certainly, alveolar liquid freedom (AFC) disappointment assumes a significant part in the pathogenesis of pneumonic edema. The unevenness of liquid digestion, pneumonic liquid leeway (PFC) and rich-protein liquid entry might be a vital justification behind the intense worsening of aspiratory edema in COVID-19 patients [2].

Here, we depict atomic components of PFC and recommend that proteins working in this cycle could act as an overlooked, however yet encouraging focuses for lessening lung edema in serious COVID-19 patients. These proteins incorporate particle channels (Na channel, K channel and TRPV4), Aquaporins (AQP), Renin Angiotensin Framework (RAS) proteins, and bradykinin/hyaluronic corrosive related catalysts. Drugs focusing in any event a portion of these proteins have proactively existed and could be reused to oversee aspiratory edema found in SARS-COV-2 contaminations. Chinese Medicine (TCMs), currently generally utilized in China, may likewise be gainful in tending to aspiratory edema in COVID-19 patients. Pneumonic edema following diuretic treatment is a possibly dangerous and under-perceived element [3,4]. An unmistakable comprehension of the systems causing this might stay away from erroneous treatment and assist with directing clinical practice. POCUS assessment is significant for precise distinguishing proof and finding of this sort of aspiratory edema.


The most well-known reason for pneumonic edema is intense decompensated cardiovascular breakdown causing hydrostatic strain aspiratory edema. Here of edema, raised left ventricular and atrial filling pressures cause development of the vascular pedicle and cephalization of vessels as aspiratory venous tension increments.


  1. Primack SL, Muller NL, Mayo JR, et al. Pulmonary parenchymal anomalies of vascular beginning: high-goal CT discoveries. Radiographics.1994;14:739-46.
  2. Indexed at, Cross Ref

  3. Laubach VE, Sharma AK. Mechanisms of lung ischemia-reperfusion injury. Physiol Behav. 2017;176:139-48.
  4. Indexed at, Google Scholar, Cross Ref

  5. Kaur SP, Gupta V. Coronavirus vaccine: a comprehensive status report. Infection Res. 2020;288:198114.
  6. Indexed at, Google Scholar, Cross Ref

  7. Achanta S, Jordt SE. Transient receptor potential channels in pulmonary chemical injuries and as countermeasure targets. Ann NY Acad Sci. 2020;1480(1):73-103.
  8. Indexed at, Google Scholar, Cross Ref

Get the App